Job title: Principal Scientist
Andrew Polson is a Principal Scientist at Genentech where he leads the development of antibody-drug conjugates and other antibody based cancer therapeutics. On these topics Andrew has over 13 corresponding author publications and is an inventor on over 15 issued patents. Prior to his 18 years at Genentech he was a postdoctoral fellow in virology at the University of California, San Francisco. He received his Ph.D. in biochemistry from the University of Utah.